Lucintel Forecasts Global Mrd Testing Market to Reach $4.4 billionby 2030.
Lucintel Forecasts Global Mrd Testing Market to Reach $4.4 billionby 2030.
Source: sandiegosun.com
📰 Mrd Testing News
Page 2 - Mrd Testing News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Mrd Testing. Real-time updates on events, politics, business and more.
Global Minimal Residual Disease Testing Market Report
Dublin, Aug. 30, 2023 (GLOBE NEWSWIRE) -- The "Minimal Residual Disease Testing: Global Markets and Technologies" report has been added to ...
United States Research Methodology Sysmex Corp Quest Diagnostics Bio Rad Laboratories Inc Guardant Health
Source: globenewswire.com
Global MRD (Minimal Residual Disease) Testing Research
Dublin, July 21, 2023 (GLOBE NEWSWIRE) -- The "MRD Testing Market - Global and Regional Analysis: Focus on Technology, Target Detection, End User and...
Source: globenewswire.com
Activity, Tolerability and Resistance Profile of the Menin Inhibitor Ziftomenib in Adults With Relapsed or Refractory NPM1-Mutated AML
Expert Amir Fathi, MD, reviews recent clinical data with ziftomenib in patients with relapsed/refractory acute myeloid leukemia.
Amir Fathi Resistance Profile Menin Inhibitor Ziftomenib Adults With Acute Myeloid Leukemia Npm1 Mutations
Source: onclive.com
Muscle-Invasive Bladder Cancer: Role of Minimal Residual Disease in Adjuvant Therapy
Continuing their discussion on adjuvant therapy in in muscle-invasive bladder cancer, panelists identify the utility of minimal residual disease testing.
Urothelial Carcinomas Invasive Bladder Cancer Minimal Residual Disease Adjuvant Therapy Bladder Cancer Urothelial Cancer
Source: onclive.com
DNA Sequencing Prior to HCT Identifies Patients at Risk of Poor AML Outcomes
A study of patients with acute myeloid leukemia (AML) in first remission found that the presence of certain variants indicative of measurable residual disease ahead of allogeneic hematopoietic cell transplant (HCT) was associated with relapse and worse survival.
Source: ajmc.com